Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Albocresil
2. Albothyl
3. Formaldehyde - Meta-cresolsulfonic Acid
4. Formaldehyde, Meta-cresolsulfonic Acid Drug Combination
5. Lotagen
6. Negatan
7. Negatol
8. Novugen
9. Policresulen
10. Vagothyl
1. Policresulen
2. 101418-00-2
3. Dihydroxydimethyldiphenylmethanedisulphonic Acid Polymer
4. Formaldehyde,2-(hydroxymethyl)benzenesulfonic Acid
5. Schembl1070408
6. Dtxsid70143913
7. Act04770
8. Bcp22334
9. Zinc4217339
10. Akos015897324
11. Bcp0726000010
12. Ft-0631012
13. 418p002
14. Q906883
15. Q-100023
16. 5,5'-(4-hydroxy-2-methyl-5-sulfo-1,3-phenylene)bis(methylene)bis(2-hydroxy-4-methylbenzenesulfonic Acid)
17. Dihydroxydimethyldiphenylmethanedisulphonic Acid Polymer, Antibiotic For Culture Media Use Only
| Molecular Weight | 588.6 g/mol |
|---|---|
| Molecular Formula | C23H24O12S3 |
| XLogP3 | 3.7 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 7 |
| Exact Mass | 588.04298972 g/mol |
| Monoisotopic Mass | 588.04298972 g/mol |
| Topological Polar Surface Area | 249 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 1140 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
D - Dermatologicals
D08 - Antiseptics and disinfectants
D08A - Antiseptics and disinfectants
D08AE - Phenol and derivatives
D08AE02 - Policresulen
G - Genito urinary system and sex hormones
G01 - Gynecological antiinfectives and antiseptics
G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids
G01AX - Other antiinfectives and antiseptics
G01AX03 - Policresulen
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
A Policresulen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Policresulen, including repackagers and relabelers. The FDA regulates Policresulen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Policresulen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Policresulen manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Policresulen supplier is an individual or a company that provides Policresulen active pharmaceutical ingredient (API) or Policresulen finished formulations upon request. The Policresulen suppliers may include Policresulen API manufacturers, exporters, distributors and traders.
click here to find a list of Policresulen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Policresulen Drug Master File in Korea (Policresulen KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Policresulen. The MFDS reviews the Policresulen KDMF as part of the drug registration process and uses the information provided in the Policresulen KDMF to evaluate the safety and efficacy of the drug.
After submitting a Policresulen KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Policresulen API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Policresulen suppliers with KDMF on PharmaCompass.
A Policresulen written confirmation (Policresulen WC) is an official document issued by a regulatory agency to a Policresulen manufacturer, verifying that the manufacturing facility of a Policresulen active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Policresulen APIs or Policresulen finished pharmaceutical products to another nation, regulatory agencies frequently require a Policresulen WC (written confirmation) as part of the regulatory process.
click here to find a list of Policresulen suppliers with Written Confirmation (WC) on PharmaCompass.
Policresulen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Policresulen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Policresulen GMP manufacturer or Policresulen GMP API supplier for your needs.
A Policresulen CoA (Certificate of Analysis) is a formal document that attests to Policresulen's compliance with Policresulen specifications and serves as a tool for batch-level quality control.
Policresulen CoA mostly includes findings from lab analyses of a specific batch. For each Policresulen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Policresulen may be tested according to a variety of international standards, such as European Pharmacopoeia (Policresulen EP), Policresulen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Policresulen USP).
LOOKING FOR A SUPPLIER?
